로딩 중…
지수 로딩 중…
Compass Therapeutics, Inc.
CMPX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$2.02-1.46%
2026-06-18
Price Chart
Compass Therapeutics, Inc.-15.13%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $364M |
| Revenue | $0.00 |
| Net Income | $-68M |
| Total Assets | $205M |
| Net Assets | $186M |
| Value | |
| P/B | 1.95x |
| FCF Yield | -14.65% |
| Profitability | |
| ROE | -36.56% |
| ROA | -33.23% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 10.03% |
| Total Debt | $10M |
| FCF | $-53M |
| Cash | $55M |
| Current Ratio | 19.04x |
| Performance | |
| 1Y Return | -15.13% |
| 1M Return | 11.60% |
| From 52W High | -70.64% |
| 1Y MDD | -75.04% |
| Trading | |
| Volume | 6,852,181 shares |
| Trading Value | $14M |
| Per Share | |
| EPS | $-0.36 |
| BPS | $1.06 |